Brett Monia spoke at Hope for ALS Dinner about the development of Qalsody

Watch the speech here:

https://video.wixstatic.com/video/f7000e_76b8f6d0b97d4c2898eb12beceae981a/1080p/mp4/file.mp4

Dr. Smith to Speak at the International ALS MND Meeting, December 6-8, 2024

The title of his talk is "Seed-Amplification Assays: Windows into ALS and Kindred Diseases".

June 2024 - Qalsody (Tofersen) Approved For Use in Europe

Qualsody/Toferson conceived by CNS Director Dr. Smith and developed in collaboration with Don Cleveland (UCSD), Tim Miller (WashU), and Frank Bennett (Ionis Pharmaceuticals), has been approved by the European Union for the treatment of a familial form of Amyotrophic lateral sclerosis (ALS). Read more here.